Question 1

What specific information will the HepQuant DuO Test provide about my liver health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease clinical trial (NCT07060547). Contact the study team or your healthcare provider for specific answers.

Question 2

How will participating in this study help me compared to standard care?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease clinical trial (NCT07060547). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or side effects of the HepQuant DuO Test?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease clinical trial (NCT07060547). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits, and what will happen during those visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease clinical trial (NCT07060547). Contact the study team or your healthcare provider for specific answers.

Question 5

Will my participation in this trial affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease clinical trial (NCT07060547). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience any issues during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease clinical trial (NCT07060547). Contact the study team or your healthcare provider for specific answers.

What this study is about